Do psoriasis drugs help or hurt your bones? study investigates
NCT ID NCT07140666
Summary
This study looked at whether two common psoriasis medications, Secukinumab and Adalimumab, affect bone health. Researchers followed 100 adults with moderate-to-severe psoriasis to see if their bone density changed over time while on one of these treatments. The goal was to gather information to help doctors choose the best treatment for patients who might also be at risk for bone loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hosptial
Beijing, Beijing Municipality, 100853, China
Conditions
Explore the condition pages connected to this study.